Legal Opinion
Sales Board v. Pfizer, Inc.
District Court, D. Minnesota
Decided August 10, 2009No. Civil 09-579 (JNE/FLN)PublishedCited by 1 opinion
1Opinion of the Court
ORDER
JOAN N. ERICKSEN, District Judge.
The Sales Board (Sales Board) asserts claims against Pfizer, Inc., for trademark infringement and unfair competition under state law and the Lanham Act, 15 U.S.C. §§ 1051-1141n (2006), based on Pfizer’s alleged use of Sales Board’s “ACTION SELLING” mark when training Pfizer’s sales representatives. The case is before the Court on Pfizer’s motion to dismiss Sales Board’s Complaint for failure to state a claim upon which relief can be granted. For the reasons set forth below, the Court grants in part and denies in part Pfizer’s motion.
I. BACKGROUND
Sales…
2Cases cited18 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- The Morningside Group Limited v. Morningside Capital Group, L.L.C.Court of Appeals for the Second Circuit · 1999
- Jessie v. PotterCourt of Appeals for the Eighth Circuit · 2008
- 1-800 Contacts, Inc. v. whenu.com, Inc. And Vision Direct, Inc.Court of Appeals for the Second Circuit · 2005
13 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Northern Spirits Stillwater LLC v. Water to Wine LLCDistrict Court, D. Minnesota · 2023